| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |